New-Onset Mediastinal and Central Nervous System Sarcoidosis in a Patient with Metastatic Melanoma Undergoing CTLA4 Monoclonal Antibody Treatment

Publisher： Karger

E-ISSN： 2296-5262|37|6|351-353

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.6, 2014-05, pp. : 351-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biochemotherapy for Metastatic Melanoma with Limited Central Nervous System Involvement

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 328-335

Karger

Access to resources Recommend Favorite

Serum S100B Levels Correlate with Clinical Benefit in a Metastatic Melanoma Patient Treated by CTLA-4 Blockade: A Case Report

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 578-581

Karger

Access to resources Recommend Favorite

CTLA‐4‐expression on VZV‐specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 151-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

New‐onset serositis in a kidney transplant patient

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 2, 2018-02 ,pp. : 518-520

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment for metastatic melanoma: a new and evolving era

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 3, 2015-03 ,pp. : 273-280

John Wiley & Sons Inc

Access to resources Recommend Favorite